Kartik Kesavabhotla

Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth

Jonathan B. Lamano, Jason Balquidera Lamano, Yuping D. Li et al. · Clinical Cancer Research · 2019 · 217 citations · Full text

Life Sciences, Immunology, Oncology +14

Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma

John A. Boockvar, Apostolos John Tsiouris, Christoph P. Hofstetter et al. · Journal of neurosurgery · 2010 · 164 citations · Full text

Medicine, Neurosurgery, Oncology +13

Zero-profile Anchored Spacer Reduces Rate of Dysphagia Compared With ACDF With Anterior Plating

Christoph P. Hofstetter, Kartik Kesavabhotla, John A. Boockvar · Journal of Spinal Disorders & Techniques · 2013 · 117 citations

Medicine, Orthopaedic Surgery, Surgery +15

Intra-Arterial Delivery of Bevacizumab after Blood-Brain Barrier Disruption for the Treatment of Recurrent Glioblastoma: Progression-Free Survival and Overall Survival

Jan‐Karl Burkhardt, Howard A. Riina, Benjamin J. Shin et al. · World Neurosurgery · 2011 · 108 citations · Full text

Medicine, Neurosurgery, Oncology +17

Using artificial intelligence (AI) to predict postoperative surgical site infection: A retrospective cohort of 4046 posterior spinal fusions

Benjamin S. Hopkins, Aditya Mazmudar, Conor Driscoll et al. · Clinical Neurology and Neurosurgery · 2020 · 104 citations

Medicine, Orthopedic Surgery, Surgery +17